CK Life Sciences Int'l., (Holdings) Inc. (HKG:0775)

HKG:0775 Balance Sheet

Financials in millions HKD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	791.11	553.97	664.32	691.93	890.8	959
Trading Asset Securities	-	17.24	11.84	12.19	11.67	12.71
Cash & Short-Term Investments	797.84	571.21	676.16	704.13	902.47	971.71
Cash Growth	41.94%	-15.52%	-3.97%	-21.98%	-7.13%	36.26%
Accounts Receivable	856.31	904.81	893.69	942.44	842.94	763.36
Other Receivables	218.42	192.13	73.29	50.9	56.32	81.38
Receivables	1,075	1,097	966.98	993.34	899.26	844.74
Inventory	1,275	1,157	1,205	1,285	1,254	1,370
Prepaid Expenses	-	139.42	144.8	142.57	113.55	105.12
Total Current Assets	3,148	2,965	2,992	3,125	3,169	3,292
Property, Plant & Equipment	4,357	4,152	4,575	4,421	4,813	4,848
Long-Term Investments	205.46	49.2	48.78	48.35	5.79	6.53
Goodwill	2,746	2,704	2,780	2,766	2,817	2,848
Other Intangible Assets	332.2	315.05	375.56	417.84	430.26	469.87
Long-Term Deferred Tax Assets	86.8	75.09	58.04	77.81	72.04	89.87
Long-Term Deferred Charges	410.69	399.79	417.51	411.37	423.64	423.3
Total Assets	11,287	10,789	11,247	11,267	11,731	11,978
Accounts Payable	261.08	332.16	358.12	412.03	278.99	314.13
Accrued Expenses	-	428.37	394.48	351.29	347.19	356.78
Current Portion of Long-Term Debt	1,131	1,277	1,150	3,056	1,224	-
Current Portion of Leases	79.48	73.74	71.78	69.42	69.11	73.7
Current Income Taxes Payable	37.76	58.63	28.69	57.67	40.15	35.79
Current Unearned Revenue	-	27.27	22.19	20.04	32.25	38.56
Other Current Liabilities	609.57	116.52	75.3	95.53	83.41	96.62
Total Current Liabilities	2,119	2,313	2,101	4,062	2,075	915.57
Long-Term Debt	4,742	4,198	4,273	2,374	4,413	5,603
Long-Term Leases	543.89	551.03	436.38	446.25	507.01	513.94
Long-Term Deferred Tax Liabilities	217.53	204.11	238.57	220.44	223.77	216.62
Total Liabilities	7,633	7,277	7,058	7,111	7,230	7,259
Common Stock	961.11	961.11	961.11	961.11	961.11	961.11
Additional Paid-In Capital	3,110	3,110	3,110	3,186	3,283	3,379
Retained Earnings	2,059	2,210	2,337	2,320	2,187	2,025
Comprehensive Income & Other	-2,477	-2,769	-2,218	-2,309	-1,927	-1,644
Total Common Equity	3,653	3,512	4,189	4,158	4,504	4,721
Minority Interest	-	-	-	-2.75	-2.74	-2.74
Shareholders' Equity	3,653	3,512	4,189	4,155	4,501	4,718
Total Liabilities & Equity	11,287	10,789	11,247	11,267	11,731	11,978
Total Debt	6,497	6,100	5,931	5,946	6,213	6,191
Net Cash (Debt)	-5,699	-5,528	-5,255	-5,242	-5,311	-5,219
Net Cash Per Share	-0.59	-0.58	-0.55	-0.55	-0.55	-0.54
Filing Date Shares Outstanding	9,611	9,611	9,611	9,611	9,611	9,611
Total Common Shares Outstanding	9,611	9,611	9,611	9,611	9,611	9,611
Working Capital	1,029	651.59	891.92	-937.48	1,094	2,376
Book Value Per Share	0.38	0.37	0.44	0.43	0.47	0.49
Tangible Book Value	574.71	492.28	1,034	974.79	1,256	1,403
Tangible Book Value Per Share	0.06	0.05	0.11	0.10	0.13	0.15
Land	622.71	512.73	651.35	608	639.59	658.22
Machinery	1,612	1,512	1,596	1,421	1,448	1,358
Construction In Progress	178.25	220.3	188.38	210.83	134.32	102.63
Leasehold Improvements	332.55	325	301.88	288.9	284.48	272.35

Source: S&P Global Market Intelligence. Standard template. Financial Sources.